Reaction Details Report a problem with these data
Target
Egl nine homolog 1 [181-417]
Ligand
BDBM475412
Substrate
n/a
Meas. Tech.
Enzyme Activity Assay
IC50
316±n/a nM
Citation
 Hocutt, FM; Leonard, Jr., BE; Peltier, HM; Phuong, VK; Rabinowitz, MH; Rosen, MD; Tarantino, KT; Venkatesan, H; Zhao, LX Benzoimidazoles as prolyl hydroxylase inhibitors US Patent  US11618744 Publication Date 4/4/2023 
Target
Name:
Egl nine homolog 1 [181-417]
Synonyms:
C1orf12 | EGLN1 | EGLN1_HUMAN | Egl nine homolog 1 (aa 181-417)
Type:
Enzyme
Mol. Mass.:
26555.51
Organism:
Homo sapiens (Human)
Description:
aa 181-417
Residue:
237
Sequence:
PNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKP
  
Inhibitor
Name:
BDBM475412
Synonyms:
1-[5-(3-Hydroxy-phenyl)-1H-benzoimidazol-2-yl]-1H- | US10851083, Example 24 | US11618744, Example 24
Type:
Small organic molecule
Emp. Form.:
C17H12N4O3
Mol. Mass.:
320.3022
SMILES:
OC(=O)c1cnn(c1)-c1nc2cc(ccc2[nH]1)-c1cccc(O)c1
Structure:
Search PDB for entries with ligand similarity: